Research output per year
Research output per year
Fingerprint
Dive into the research topics where Thomas Lund is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Researchers
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Research output
-
In multiple myeloma, monthly treatment with zoledronic acid beyond two years offers sustained protection against progressive bone disease
Lund, T., Gundesen, M. T., Juul Vangsted, A., Helleberg, C., Haukås, E., Silkjær, T., Asmussen, J. T., Manuela Teodorescu, E., Amdi Jensen, B., Schmidt Slørdahl, T., Nahi, H., Waage, A., Abildgaard, N. & Schjesvold, F., 15. Apr 2024, In: Blood Cancer Journal. 14, 5 p., 65.Research output: Contribution to journal › Comment/debate › Research › peer-review
Open AccessFile6 Downloads (Pure) -
Making decisions for follow-up chemotherapy based on digital patient reported outcomes data in patients with multiple myeloma and other M protein diseases – A mixed method study
Rosenberg, T., Kirkegaard, J., Tveden, M. G., Hyldig, N., Dieperink, K. B., Steffensen, N. H., Ulriksen, S. B. & Lund, T., Feb 2024, In: European Journal of Oncology Nursing. 68, 102455.Research output: Contribution to journal › Journal article › Research › peer-review
Open AccessFile43 Downloads (Pure) -
Nationwide implementation of lenalidomide maintenance in multiple myeloma: A retrospective, real-world study
Harsløf, M., Chanchiri, I., Silkjær, T., Frølund, U. C., Teodorescu, E. M., Nielsen, K. B., Nielsen, P. I., Pedersen, P. T., Iversen, K. F., Lund, T., Grønbæk, K., Thorsteinsdottir, S., Vangsted, A. & Szabo, A. G., Apr 2024, In: eJHaem. 5, 2, p. 316-324Research output: Contribution to journal › Journal article › Research › peer-review
Open AccessFile20 Downloads (Pure) -
Novel CCL3-HMGB1 signaling axis regulating osteocyte RANKL expression in multiple myeloma
Anloague, A., Sabol, H. M., Kaur, J., Khan, S., Ashby, C., Schinke, C., Barnes, C. L., Alturkmani, F., Ambrogini, E., Gundesen, M. T., Lund, T., Amstrup, A. K., Andersen, T. L., Diaz-delCastillo, M., Roodman, G. D., Bellido, T. & Delgado-Calle, J., 28. Nov 2024, In: Haematologica.Research output: Contribution to journal › Journal article › Research › peer-review
-
A multiple myeloma plasma extracellular vesicle protein signature for monitoring patient response to daratumumab
Andersen, T. L. & Lund, T., May 2023.Research output: Contribution to conference without publisher/journal › Conference abstract for conference › Research › peer-review
Activities
-
Treatment of bone disease in multiple Myeloma
Lund, T. (Lecturer)
30. May 2024Activity: Talks and presentations › Talks and presentations in private or public companies
-
Treatment at home
Lund, T. (Lecturer)
11. Mar 2024Activity: Talks and presentations › Talks and presentations in private or public companies
-
Home treatment and dosing of follow-up anti-neoplastic treatment based on digital patient reported outcomes data in patients with multiple myeloma
Lund, T. (Guest lecturer)
9. Mar 2024Activity: Talks and presentations › Talks and presentations in private or public companies
-
-
Post ASH. Multiple Myeloma
Lund, T. (Guest lecturer)
24. Jan 2023Activity: Talks and presentations › Talks and presentations in private or public companies
Press/Media
-
Overlæge om afslag til to lægemidler mod knoglemarvskræft: Det er frustrerende
29/10/2024
1 Media contribution
Press/Media: Press / Media
-
Overlæge om afslag til to lægemidler mod knoglemarvskræft: Det er frustrerende
29/10/2024
1 Media contribution
Press/Media: Press / Media
-
Overlæge om afslag til to bispecifikke antistoffer mod MM: Det er frustrerende
27/10/2024
1 Media contribution
Press/Media: Press / Media
-
Sag om grov udnyttelse har fået en lykkelig udgang
15/04/2024
1 Media contribution
Press/Media: Press / Media
-
Sag om grov udnyttelse har fået en lykkelig udgang
15/04/2024
1 Media contribution
Press/Media: Press / Media